RIFAMPICIN RESISTANT TUBERCULOSIS
Clinical trials for RIFAMPICIN RESISTANT TUBERCULOSIS explained in plain language.
Never miss a new study
Get alerted when new RIFAMPICIN RESISTANT TUBERCULOSIS trials appear
Sign up with your email to follow new studies for RIFAMPICIN RESISTANT TUBERCULOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
China tests 9-Month pill regimen to fight tough tuberculosis
Disease control Not yet recruitingThis study is testing a shorter, all-pill treatment for a difficult form of tuberculosis (TB) that resists standard antibiotics. It will enroll 120 Chinese participants aged 12 and older to see if a 9-month course of four specific oral drugs is effective and safe. The goal is to …
Matched conditions: RIFAMPICIN RESISTANT TUBERCULOSIS
Phase: PHASE3 • Sponsor: Beijing Chest Hospital • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
Breakthrough hope for Drug-Resistant TB: shorter treatment with new pill
Disease control Not yet recruitingThis study is testing whether adding a new drug called acetohydroxamic acid (AHA) to existing shorter treatment regimens can help people with multidrug-resistant tuberculosis. Researchers will enroll 120 participants to see if the combination is safe and effective at clearing the…
Matched conditions: RIFAMPICIN RESISTANT TUBERCULOSIS
Phase: PHASE2 • Sponsor: Shanghai Pulmonary Hospital, Shanghai, China • Aim: Disease control
Last updated Mar 19, 2026 14:56 UTC